Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Brazil · Delayed Price · Currency is BRL 0.7200
+0.0100 (1.41%)
Oct 28, 2026, 5:05 PM GMT-3
BVMF:ONCO3 Ratios and Metrics
Market cap in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 808 | 3,019 | 1,481 | 6,603 | 2,889 | 5,254 | |
Market Cap Growth | -64.63% | 103.88% | -77.57% | 128.55% | -45.01% | - |
Enterprise Value | 4,656 | 7,706 | 5,520 | 10,062 | 5,826 | 5,343 |
Last Close Price | 0.71 | 2.71 | 2.25 | 12.51 | 5.80 | 10.82 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 29.53 | 62.45 | - |
Forward PE | 19.51 | 27.76 | 4.37 | 19.47 | 18.06 | 22.45 |
PS Ratio | 0.16 | 0.53 | 0.24 | 1.20 | 0.71 | 1.94 |
PB Ratio | 8.11 | 2.84 | 0.44 | 2.46 | 1.10 | 2.28 |
PEG Ratio | - | 19.01 | 0.06 | 0.20 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.93 | 1.34 | 0.89 | 1.83 | 1.43 | 1.98 |
EV/EBITDA Ratio | - | - | 6.31 | 10.81 | 9.02 | 19.77 |
EV/EBIT Ratio | - | - | 8.07 | 13.07 | 12.37 | 30.15 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 39.49 | 3.63 | 1.65 | 1.71 | 1.33 | 1.06 |
Debt / EBITDA Ratio | - | - | 5.83 | 4.54 | 5.40 | 8.16 |
Debt / FCF Ratio | 21.84 | - | - | - | - | - |
Net Debt / Equity Ratio | 38.34 | 3.15 | 1.09 | 1.42 | 0.91 | 0.18 |
Net Debt / EBITDA Ratio | -2.01 | -2.80 | 4.20 | 4.09 | 3.71 | 1.57 |
Net Debt / FCF Ratio | 21.20 | -11.65 | -9.20 | -10.48 | -4.19 | -2.00 |
Asset Turnover | 0.59 | 0.63 | 0.61 | 0.63 | 0.57 | 0.57 |
Inventory Turnover | 16.96 | 19.25 | 19.31 | 19.23 | 22.59 | 34.44 |
Quick Ratio | 0.31 | 0.43 | 1.73 | 1.55 | 1.39 | 2.29 |
Current Ratio | 0.44 | 0.56 | 1.90 | 1.71 | 1.50 | 2.41 |
Return on Equity (ROE) | -273.51% | -165.19% | -23.67% | 11.77% | 4.61% | -1.50% |
Return on Assets (ROA) | -15.09% | -9.31% | 4.20% | 5.53% | 4.13% | 2.35% |
Return on Invested Capital (ROIC) | -49.68% | -23.83% | 10.10% | 13.37% | 11.37% | -3.00% |
Return on Capital Employed (ROCE) | -286.60% | -70.80% | 7.80% | 10.50% | 7.40% | 3.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -676.27% | -120.04% | -43.64% | 3.39% | 1.60% | -0.89% |
FCF Yield | 22.29% | -9.50% | -26.95% | -5.50% | -19.79% | -4.02% |
Payout Ratio | - | - | - | 26.70% | 39.54% | - |
Buyback Yield / Dilution | -32.66% | -40.59% | -15.09% | -0.72% | -28.93% | -2.65% |